Home
LiteratureArticle Details
PMID: 4580857
Published · ppublish
English
Journal Article
Review
Rationale of combination chemotherapy based on preclinical experiments.
Cancer chemotherapy reports. Part 3
·Vol. 4
·No. 2
·1973-03-00
·Pages 189-98
Abstract
暂无摘要
MeSH Terms
Animals
Antineoplastic Agents/administration & dosage,adverse effects,therapeutic use
Azaguanine/therapeutic use
Carcinoma/drug therapy
Cytarabine/therapeutic use
Drug Synergism
Humans
Hydroxyurea/therapeutic use
Immunotherapy
Leukemia L1210/drug therapy
Lung Neoplasms/drug therapy
Melanoma/drug therapy
Neoplasms/drug therapy,surgery,therapy
Thiosemicarbazones/therapeutic use
Time Factors
Chemicals
Antineoplastic Agents
Thiosemicarbazones
Cytarabine
Azaguanine
Hydroxyurea
Article Info
Journal
Cancer chemotherapy reports. Part 3
Abbr.
Cancer Chemother Rep 3
ISSN
0069-0139
Published
1973-03-00
Pages
189-98
Language
English
Region
United States
NLM ID
7609154
Subset
IM
External Links
PubMed source
Analysis Services
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
